Choriocarcinoma

Choriocarcinoma is a rare type of cancer that develops in the cells that would normally form the placenta during pregnancy. It primarily affects the reproductive system, especially the uterus, and can occur after a normal pregnancy, miscarriage, or molar pregnancy. This cancer grows rapidly and can spread to other parts of the body, such as the lungs or brain, causing serious health problems. One of the main signs is abnormal vaginal bleeding, which may be accompanied by symptoms related to metastasis. The disease is characterized by high levels of a hormone called human chorionic gonadotropin (hCG), which can be detected in blood tests. Early diagnosis and treatment are crucial because this cancer can be aggressive but is often responsive to chemotherapy.

Choriocarcinoma is a highly malignant trophoblastic tumor arising from abnormal proliferation of cytotrophoblast and syncytiotrophoblast cells, typically following a gestational event such as a molar pregnancy, normal pregnancy, or abortion. It is characterized by the absence of villous structures and marked by extensive hemorrhage and necrosis. The tumor produces excessive human chorionic gonadotropin (hCG), which serves as a key tumor marker. Clinically, it presents with symptoms related to uterine invasion and distant metastases, most commonly to the lungs and brain. The aggressive nature of this tumor necessitates prompt recognition and treatment. It is a subtype of gestational trophoblastic disease and is distinguished from other trophoblastic tumors by its rapid growth and high metastatic potential.